The NCRI LWBC Group brings together clinicians, scientists and patients, carers and others affected by cancer (also known as ‘consumers’), amongst many others, to coordinate the development of a strategic portfolio of research within the field of living with and beyond cancer 

The NCRI LWBC Group aims to improve the quality, and increase the quantity, of multidisciplinary research into outcomes for people affected by cancer at all stages of disease; and for their carers. The NCRI LWBC Group covers all cancer types and patients at all stages of illness, including those without a current histological diagnosis. It includes all aspects of patient and carer wellbeing and will cover physical, psychological, social, spiritual, cultural, and financial consequences of cancer illness. 

The NCRI LWBC Group consists of an executive group, chaired by Professor Galina Velikova, which provides oversight of the research landscape and proactively identifies opportunities for the group. The LWBC Group also has several subgroups that develop research in areas of strategic need.

Members are competitively recruited to the executive Group and subgroups twice a year and are advertised on the jobs and opportunities page. If there are not currently any vacancies, you are encouraged to register your interest via email.

NCRI LWBC Group Objectives:

  1. Raise awareness of research into outcomes for people with cancer at all stages of disease, including long-term survivorship and at end of life; and for their carers.
  2. Stimulate new studies using a range of current and innovative approaches, into improving and measuring outcomes.
  3. Design and secure funding for research supporting our aim.
  4. Collaborate with other research groups both in the UK and abroad to achieve our aim
  5. Seek new sources of funding for research meeting our aim.
  6. Increasing outputs of the Group with respect to publications and presentations.
  7. Advise and support other researchers in the NCRI to design their own studies into measuring and improving patient outcomes.

Group Chair: Professor Galina Velikova